Baxter International (BAX) Stock Buyback History
TTM buyback yield N/A.
TTM buyback yield
N/A
Shareholder yield (TTM)
N/A
5Y share count change
-0.8%
TTM buyback spend
N/A
SBC coverage (TTM)
0.00x
YoY change in spend
N/A
5Y CAGR of spend
-100.0%
Peak year (2018)
$2.45B
Cumulative spend
$21.88B
TTM metrics calculated from the four most recent reported quarters, ending (reported ).
Key takeaways
- Diluted share count is roughly flat (-0.8%) over the last ~5 fiscal years — buybacks are offsetting dilution but not shrinking the float.
- Cash buyback spend has compounded at -100.0% per year over the latest 5-year window.
- TTM repurchases used about 0% of free cash flow remaining after dividends.
Buyback context per fiscal year
Annual repurchases alongside stock-based compensation, diluted share count and the year-over-year change — useful for SBC-coverage and dilution-offset reading at a glance.
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $0.00 | $117.00M | −$117.00M | 0.51B | 0.6% | — |
| 2024 | $0.00 | $114.00M | −$114.00M | 0.51B | 0.8% | — |
| 2023 | $0.00 | $115.00M | −$115.00M | 0.51B | 0.4% | — |
| 2022 | $32.00M | $140.00M | −$108.00M | 0.50B | -0.8% | 0.12% |
| 2021 | $600.00M | $146.00M | $454.00M | 0.51B | -1.7% | 1.40% |
| 2020 | $500.00M | $130.00M | $370.00M | 0.52B | -0.4% | 1.22% |
| 2019 | $1.27B | $122.00M | $1.15B | 0.52B | -4.9% | 3.00% |
| 2018 | $2.45B | $115.00M | $2.34B | 0.55B | -1.6% | 7.06% |
| 2017 | $564.00M | $107.00M | $457.00M | 0.56B | 0.7% | 1.61% |
| 2016 | $292.00M | $115.00M | $177.00M | 0.55B | 0.4% | 1.22% |
| 2015 | $0.00 | $126.00M | −$126.00M | 0.55B | 0.4% | — |
| 2014 | $550.00M | $126.00M | $424.00M | 0.55B | -0.4% | 2.55% |
| 2013 | $913.00M | $122.00M | $791.00M | 0.55B | -1.3% | 4.45% |
| 2012 | $1.48B | $130.00M | $1.35B | 0.56B | -3.0% | 7.46% |
| 2011 | $1.58B | $119.00M | $1.46B | 0.57B | -3.5% | 10.48% |
| 2010 | $1.45B | $120.00M | $1.33B | 0.59B | -3.3% | 9.16% |
| 2009 | $1.22B | $140.00M | $1.08B | 0.61B | -3.6% | 6.34% |
| 2008 | $1.99B | $146.00M | $1.84B | 0.64B | -2.6% | 11.13% |
| 2007 | $1.85B | $136.00M | $1.72B | 0.65B | -0.3% | 9.31% |
| 2006 | $737.00M | $0.00 | $737.00M | 0.66B | 4.3% | 4.50% |
| 2005 | $0.00 | $0.00 | $0.00 | 0.63B | 1.8% | — |
| 2004 | $18.00M | $0.00 | $18.00M | 0.62B | 7.0% | 0.16% |
| 2003 | $714.00M | $0.00 | $714.00M | 0.58B | 24.3% | 7.04% |
| 2002 | $1.17B | $0.00 | $1.17B | 0.46B | -17.3% | 12.85% |
| 2001 | $288.00M | $0.00 | $288.00M | 0.56B | -5.2% | 1.65% |
| 2000 | $375.00M | $0.00 | $375.00M | 0.59B | 0.3% | — |
| 1999 | $184.00M | $0.00 | $184.00M | 0.59B | 2.1% | — |
| 1998 | $0.00 | $0.00 | $0.00 | 0.58B | 2.5% | — |
| 1997 | $0.00 | $0.00 | $0.00 | 0.56B | 2.2% | — |
| 1996 | $267.00M | $0.00 | $267.00M | 0.55B | — | — |
| 1995 | $500.00M | $0.00 | $500.00M | — | — | — |
| 1994 | $47.00M | $0.00 | $47.00M | — | — | — |
| 1993 | $124.00M | $0.00 | $124.00M | — | — | — |
| 1992 | $460.00M | $0.00 | $460.00M | — | — | — |
| 1991 | $109.00M | $0.00 | $109.00M | — | — | — |
| 1990 | $132.00M | $0.00 | $132.00M | — | — | — |
| 1989 | $7.00M | $0.00 | $7.00M | — | — | — |
Cash buyback spend (USD) — annual & quarterly history
Trailing-twelve-month and per-period cash repurchases for Baxter International (BAX) from the consolidated cash flow statement (line: common stock repurchased), in USD as filed.
Cash buyback spend over time for Baxter International (BAX)
Per-period cash repurchases
Cash buyback spend annual + quarterly history for Baxter International (BAX)
| Fiscal year | Period ended | Reported | Buyback Spend | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $0 | — | $0 | ||
| 2024 | $0 | — | $0 | ||
| 2023 | $0 | -100.0% | -$32.00M | ||
| 2022 | $32.00M | -94.7% | -$568.00M | ||
| 2021 | $600.00M | +20.0% | +$100.00M | ||
| 2020 | $500.00M | -60.6% | -$770.00M | ||
| 2019 | $1.27B | -48.2% | -$1.18B | ||
| 2018 | $2.45B | +334.8% | +$1.89B | ||
| 2017 | $564.00M | +93.2% | +$272.00M | ||
| 2016 | $292.00M | — | +$292.00M | ||
| 2015 | $0 | -100.0% | -$550.00M | ||
| 2014 | $550.00M | -39.8% | -$363.00M | ||
| 2013 | $913.00M | -38.3% | -$567.00M | ||
| 2012 | $1.48B | -6.5% | -$103.00M | ||
| 2011 | $1.58B | +8.9% | +$130.00M | ||
| 2010 | $1.45B | +19.5% | +$237.00M | ||
| 2009 | $1.22B | -38.8% | -$770.00M | ||
| 2008 | $1.99B | +7.1% | +$131.00M | ||
| 2007 | $1.85B | +151.7% | +$1.12B | ||
| 2006 | $737.00M | — | +$737.00M | ||
| 2005 | $0 | -100.0% | -$18.00M | ||
| 2004 | $18.00M | -97.5% | -$696.00M | ||
| 2003 | $714.00M | -38.9% | -$455.00M | ||
| 2002 | $1.17B | +305.9% | +$881.00M | ||
| 2001 | $288.00M | -23.2% | -$87.00M | ||
| 2000 | $375.00M | +103.8% | +$191.00M | ||
| 1999 | $184.00M | — | +$184.00M | ||
| 1998 | $0 | — | $0 | ||
| 1997 | $0 | -100.0% | -$267.00M | ||
| 1996 | $267.00M | -46.6% | -$233.00M | ||
| 1995 | $500.00M | +963.8% | +$453.00M | ||
| 1994 | $47.00M | -62.1% | -$77.00M | ||
| 1993 | $124.00M | -73.0% | -$336.00M | ||
| 1992 | $460.00M | +322.0% | +$351.00M | ||
| 1991 | $109.00M | -17.4% | -$23.00M | ||
| 1990 | $132.00M | +1785.7% | +$125.00M | ||
| 1989 | $7.00M | — | — |
As of the 2025 fiscal year, Baxter International (BAX) reported buyback spend of $0.
Baxter International buyback spend compound annual growth for the 2020–2025 (5 years) window is -100.0%, with a net decline across the window.
Between 2018 and 2025, Baxter International buyback spend plunged 100.0%, falling from $2.45B to $0.
The dataset's maximum buyback spend sits at $2.45B (2018); the minimum reading of $0 dates to 1997.
Within Healthcare, Baxter International (BAX) ranks 8th among 8 peers we track. The peer median for buyback spend is $2.75B.
Baxter International Buyback Spend 2025: $0
Baxter International buyback spend in 2025 was $0.
Baxter International Buyback Spend 2024: $0
Baxter International buyback spend in 2024 was $0.
Baxter International Buyback Spend 2023: $0
Baxter International buyback spend in 2023 was $0, plunged 100.0% below 2022.
Baxter International Buyback Spend 2022: $32.00M
Baxter International buyback spend in 2022 was $32.00M, plunged 94.7% below 2021.
Baxter International Buyback Spend 2021: $600.00M
Baxter International buyback spend in 2021 was $600.00M.
See more financial history for Baxter International (BAX).
Sector peers by buyback spend
Companies in the same sector as Baxter International, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group (UNH) | $5.54B | Healthcare |
| Merck & Co. (MRK) | $5.08B | Healthcare |
| Eli Lilly (LLY) | $4.11B | Healthcare |
| Novo Nordisk (NVO) | $1.39B | Healthcare |
| AbbVie (ABBV) | $980.00M | Healthcare |
| AstraZeneca (AZN) | $719.66M | Healthcare |
| Amgen (AMGN) | $0 | Healthcare |
Share count history
Diluted weighted-average shares drive the EPS denominator and per-share capital-return maths. A falling diluted share count means buybacks are outpacing dilution from stock-based compensation and option exercises.
Diluted vs basic shares (annual)
Year-over-year change in diluted shares
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield over time
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Buybacks vs stock-based compensation
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 0.00×.
Capital allocation mix
How Baxter International splits cash returned to shareholders between dividends and buybacks, plus the headroom on free cash flow that's still available for additional repurchases.
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $448.00M (TTM FCF − TTM dividends, clamped at zero).
Data & methodology
Where do buyback, dividend and compensation figures come from?
Cash buyback spend (common stock repurchased), dividends paid and stock-based compensation come from Baxter International's consolidated cash flow statements — quarterly 10-Q and annual 10-K SEC filings, in USD as reported.
How are diluted shares and yields calculated?
Diluted weighted-average share counts come from the income statement (EPS denominator). Trailing twelve-month (TTM) aggregates sum the four most recent reported quarters. Buyback and dividend yields divide TTM cash flows by market capitalisation at the latest quarter-end.
How is buyback capacity defined?
Capacity compares TTM repurchases to free cash flow after dividends: operating cash flow minus capital expenditure, minus dividends paid, versus actual buybacks over the same trailing window.
Is this investment advice?
No. Figures are for informational and educational use only. Past buybacks and dividends do not predict future returns.
Frequently asked questions
Does Baxter International buy back its own stock?
Yes, Baxter International (BAX) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
Is Baxter International diluting shareholders?
Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Baxter International's share count changed?
Diluted weighted average shares changed by about -0.8% over roughly five fiscal years (annual income statement data).
What is Baxter International's buyback spend?
Latest reported buyback spend for Baxter International (BAX) is $0 (period ending March 31, 2026).
What is the long-term growth rate of Baxter International buyback spend?
Baxter International (BAX) buyback spend compound annual growth rate is -100.0% over the most recent 5 years available.
When did Baxter International buyback spend hit its highest annual value?
Baxter International buyback spend reached its highest annual value of $2.45B in 2018.
What was Baxter International buyback spend in 2024?
Baxter International (BAX) buyback spend in 2024 was $0.
What was Baxter International buyback spend in 2025?
Baxter International (BAX) buyback spend in 2025 was $0.
Explore more
BAX Overview
Company profile, financial tools, and key metrics
BAX Revenue Counter
Earns $358.95 every second. See per minute, hour, and day.
BAX Earnings Counter
Loses −$34.82 per second. See per minute, hour, and day.
BAX Economic Scale
Exceeds Malawi's GDP. Compare with world economies.
BAX What If Invested
What if you had invested $1,000? See historical returns from any date.
BAX How It Makes Money
Discover visual breakdown of $11.32B in revenue — where it comes from and where it goes.
BAX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BAX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BAX Daily Price Character
Steady · 48.4% historical win rate (green days). Streaks & record days.
BAX Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
BAX Dividend Profile
Yield: 1.92%. Safety: 3/8. See full history.
BAX Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BAX Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.
BAX Dividend Capture
Historical pre-ex touch stats, gap distribution, after-tax calculator, and a backtest simulator (limit-order vs MOC exit).
BAX Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.